STOCK TITAN

[SCHEDULE 13D/A] LiveOne, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Safety Shot, Inc. (NASDAQ:SHOT) reported that on 21 Jul 2025 it signed a Securities Purchase Agreement for a registered direct offering of 22,993,492 common shares at $0.461 per share and a concurrent private placement of 45,986,984 unregistered five-year warrants priced at $0.125 each, exercisable at the same $0.461 strike. Together, the transactions closed on 24 Jul 2025 and generated gross proceeds of approximately $16.3 million before expenses.

Placement agent Dominari Securities LLC will receive an 8% cash commission, a 1% expense allowance and $150,000 for legal/out-of-pocket costs, plus 1,839,479 five-year warrants exercisable at $0.461. The company will file an S-1 within ten days to register the resale of warrant shares, with effectiveness required within 45 days (75 days if subject to full SEC review).

Use of proceeds: working capital and general corporate purposes. Assuming full warrant exercise, the deal could add up to 70.8 million new shares, materially diluting existing holders while improving near-term liquidity.

Safety Shot, Inc. (NASDAQ:SHOT) ha annunciato che il 21 luglio 2025 ha sottoscritto un Accordo di Acquisto di Titoli per un offerta diretta registrata di 22.993.492 azioni ordinarie al prezzo di 0,461 $ per azione e un contestuale collocamento privato di 45.986.984 warrant quinquennali non registrati al prezzo di 0,125 $ ciascuno, esercitabili allo stesso prezzo di esercizio di 0,461 $. Le operazioni si sono concluse il 24 luglio 2025, generando proventi lordi di circa 16,3 milioni di dollari prima delle spese.

L'agente di collocamento Dominari Securities LLC riceverà una commissione in contanti dell'8%, un rimborso spese dell'1% e 150.000 $ per costi legali e spese varie, oltre a 1.839.479 warrant quinquennali esercitabili a 0,461 $. La società presenterà un modulo S-1 entro dieci giorni per registrare la rivendita delle azioni derivanti dai warrant, con efficacia richiesta entro 45 giorni (75 giorni in caso di revisione completa da parte della SEC).

Utilizzo dei proventi: capitale circolante e scopi aziendali generali. In caso di esercizio completo dei warrant, l’operazione potrebbe aggiungere fino a 70,8 milioni di nuove azioni, diluendo significativamente gli azionisti attuali ma migliorando la liquidità a breve termine.

Safety Shot, Inc. (NASDAQ:SHOT) informó que el 21 de julio de 2025 firmó un Acuerdo de Compra de Valores para una oferta directa registrada de 22,993,492 acciones comunes a $0.461 por acción y una colocación privada concurrente de 45,986,984 warrants quinquenales no registrados a un precio de $0.125 cada uno, ejercitables al mismo precio de ejercicio de $0.461. Ambas transacciones se cerraron el 24 de julio de 2025, generando ingresos brutos de aproximadamente $16.3 millones antes de gastos.

El agente colocador Dominari Securities LLC recibirá una comisión en efectivo del 8%, una asignación de gastos del 1% y $150,000 para costos legales y otros gastos, además de 1,839,479 warrants quinquenales ejercitables a $0.461. La compañía presentará un formulario S-1 dentro de diez días para registrar la reventa de las acciones de los warrants, con efectividad requerida dentro de 45 días (75 días si está sujeto a una revisión completa de la SEC).

Uso de los ingresos: capital de trabajo y propósitos corporativos generales. Suponiendo el ejercicio total de los warrants, la operación podría añadir hasta 70.8 millones de nuevas acciones, diluyendo materialmente a los accionistas existentes mientras mejora la liquidez a corto plazo.

Safety Shot, Inc. (NASDAQ:SHOT)는 2025년 7월 21일에 22,993,492주 보통주에 대한 등록 직접 공모를 주당 $0.461에 체결하고, 동시에 45,986,984주의 등록되지 않은 5년 만기 워런트를 주당 $0.125에 발행했으며, 워런트 행사가격은 동일하게 $0.461입니다. 이 거래들은 2025년 7월 24일에 완료되어, 비용 차감 전 약 1,630만 달러의 총 수익을 창출했습니다.

배정 대행사인 Dominari Securities LLC는 8% 현금 수수료, 1% 비용 수당, 법률 및 기타 비용으로 $150,000를 받으며, 추가로 1,839,479주의 5년 만기 워런트를 행사가 $0.461에 받게 됩니다. 회사는 워런트 주식 재판매 등록을 위해 10일 이내에 S-1 서류를 제출할 예정이며, 효력 발생은 45일 이내(SEC 전면 검토 시 75일)여야 합니다.

자금 사용처: 운전자본 및 일반 기업 목적. 워런트가 전부 행사될 경우, 이번 거래로 최대 7,080만 주의 신주가 발행되어 기존 주주들의 지분 희석이 발생하지만 단기 유동성은 개선될 것입니다.

Safety Shot, Inc. (NASDAQ:SHOT) a annoncé que le 21 juillet 2025, elle a signé un accord d'achat de titres pour une offre directe enregistrée de 22 993 492 actions ordinaires au prix de 0,461 $ par action, ainsi qu'un placement privé simultané de 45 986 984 bons de souscription non enregistrés d'une durée de cinq ans au prix de 0,125 $ chacun, exerçables au même prix d'exercice de 0,461 $. Ces transactions ont été clôturées le 24 juillet 2025, générant des produits bruts d'environ 16,3 millions de dollars avant frais.

L'agent de placement Dominari Securities LLC recevra une commission en espèces de 8 %, une indemnité de 1 % pour frais et 150 000 $ pour les coûts juridiques et autres dépenses, ainsi que 1 839 479 bons de souscription de cinq ans exerçables à 0,461 $. La société déposera un formulaire S-1 dans les dix jours pour enregistrer la revente des actions issues des bons, avec une entrée en vigueur requise sous 45 jours (75 jours en cas d'examen complet par la SEC).

Utilisation des fonds : fonds de roulement et objectifs généraux de l'entreprise. En supposant l'exercice complet des bons, l'opération pourrait ajouter jusqu'à 70,8 millions de nouvelles actions, diluant significativement les actionnaires actuels tout en améliorant la liquidité à court terme.

Safety Shot, Inc. (NASDAQ:SHOT) gab bekannt, dass am 21. Juli 2025 ein Wertpapierkaufvertrag für ein registriertes Direktangebot von 22.993.492 Stammaktien zu je 0,461 $ sowie eine gleichzeitige private Platzierung von 45.986.984 nicht registrierten fünfjährigen Warrants zu je 0,125 $ mit Ausübungspreis von 0,461 $ unterzeichnet wurde. Die Transaktionen wurden am 24. Juli 2025 abgeschlossen und erzielten Bruttoerlöse von ca. 16,3 Millionen US-Dollar vor Kosten.

Der Platzierungsagent Dominari Securities LLC erhält eine Barausschüttung von 8 %, eine Aufwandspauschale von 1 % sowie 150.000 $ für Rechts- und sonstige Kosten sowie 1.839.479 fünfjährige Warrants mit Ausübungspreis von 0,461 $. Das Unternehmen wird innerhalb von zehn Tagen ein S-1-Formular einreichen, um den Weiterverkauf der Warrants-Aktien zu registrieren, mit Wirksamkeit innerhalb von 45 Tagen (75 Tage bei vollständiger SEC-Prüfung).

Verwendung der Erlöse: Betriebskapital und allgemeine Unternehmenszwecke. Bei vollständiger Ausübung der Warrants könnten bis zu 70,8 Millionen neue Aktien ausgegeben werden, was die bestehenden Aktionäre erheblich verwässert, aber die kurzfristige Liquidität verbessert.

Positive
  • $16.3 million gross proceeds strengthen liquidity without incurring debt
  • Immediate five-year warrants could raise additional cash if exercised
  • Obligation to file S-1 within 10 days enhances transparency for warrant holders
Negative
  • Up to 70.8 million new shares if all warrants are exercised, creating significant dilution
  • Low offering price of $0.461 may signal weak market demand
  • High 8% placement fee plus additional costs increase transaction expense burden

Insights

TL;DR: Raises $16.3 m but introduces heavy dilution risk.

The company bolsters cash with a quick registered direct/PIPE mix, avoiding the delays of a public follow-on. Pricing at $0.461 suggests limited bargaining power, yet the immediate capital infusion supports operations without new debt. However, up to 70.8 m incremental shares (≈ triple current shares outstanding) could pressure valuation and elevate volatility. Accelerated S-1 filing shows intent to facilitate secondary liquidity, potentially accelerating warrant exercises if the stock rallies. Overall impact: neutral—liquidity gain offsets dilution.

TL;DR: Standard terms, but large warrant overhang raises governance concerns.

Indemnities, reps and covenants appear customary. Dominari’s fee package is market-standard, though the 8% cash fee on a sub-$20 m raise is on the high side. The company’s obligation to register resale shares within 45 days places administrative burden but is manageable. Key risk is shareholder dilution and potential downward pressure from warrant arbitrage. No change to control provisions, so governance impact is moderate.

Safety Shot, Inc. (NASDAQ:SHOT) ha annunciato che il 21 luglio 2025 ha sottoscritto un Accordo di Acquisto di Titoli per un offerta diretta registrata di 22.993.492 azioni ordinarie al prezzo di 0,461 $ per azione e un contestuale collocamento privato di 45.986.984 warrant quinquennali non registrati al prezzo di 0,125 $ ciascuno, esercitabili allo stesso prezzo di esercizio di 0,461 $. Le operazioni si sono concluse il 24 luglio 2025, generando proventi lordi di circa 16,3 milioni di dollari prima delle spese.

L'agente di collocamento Dominari Securities LLC riceverà una commissione in contanti dell'8%, un rimborso spese dell'1% e 150.000 $ per costi legali e spese varie, oltre a 1.839.479 warrant quinquennali esercitabili a 0,461 $. La società presenterà un modulo S-1 entro dieci giorni per registrare la rivendita delle azioni derivanti dai warrant, con efficacia richiesta entro 45 giorni (75 giorni in caso di revisione completa da parte della SEC).

Utilizzo dei proventi: capitale circolante e scopi aziendali generali. In caso di esercizio completo dei warrant, l’operazione potrebbe aggiungere fino a 70,8 milioni di nuove azioni, diluendo significativamente gli azionisti attuali ma migliorando la liquidità a breve termine.

Safety Shot, Inc. (NASDAQ:SHOT) informó que el 21 de julio de 2025 firmó un Acuerdo de Compra de Valores para una oferta directa registrada de 22,993,492 acciones comunes a $0.461 por acción y una colocación privada concurrente de 45,986,984 warrants quinquenales no registrados a un precio de $0.125 cada uno, ejercitables al mismo precio de ejercicio de $0.461. Ambas transacciones se cerraron el 24 de julio de 2025, generando ingresos brutos de aproximadamente $16.3 millones antes de gastos.

El agente colocador Dominari Securities LLC recibirá una comisión en efectivo del 8%, una asignación de gastos del 1% y $150,000 para costos legales y otros gastos, además de 1,839,479 warrants quinquenales ejercitables a $0.461. La compañía presentará un formulario S-1 dentro de diez días para registrar la reventa de las acciones de los warrants, con efectividad requerida dentro de 45 días (75 días si está sujeto a una revisión completa de la SEC).

Uso de los ingresos: capital de trabajo y propósitos corporativos generales. Suponiendo el ejercicio total de los warrants, la operación podría añadir hasta 70.8 millones de nuevas acciones, diluyendo materialmente a los accionistas existentes mientras mejora la liquidez a corto plazo.

Safety Shot, Inc. (NASDAQ:SHOT)는 2025년 7월 21일에 22,993,492주 보통주에 대한 등록 직접 공모를 주당 $0.461에 체결하고, 동시에 45,986,984주의 등록되지 않은 5년 만기 워런트를 주당 $0.125에 발행했으며, 워런트 행사가격은 동일하게 $0.461입니다. 이 거래들은 2025년 7월 24일에 완료되어, 비용 차감 전 약 1,630만 달러의 총 수익을 창출했습니다.

배정 대행사인 Dominari Securities LLC는 8% 현금 수수료, 1% 비용 수당, 법률 및 기타 비용으로 $150,000를 받으며, 추가로 1,839,479주의 5년 만기 워런트를 행사가 $0.461에 받게 됩니다. 회사는 워런트 주식 재판매 등록을 위해 10일 이내에 S-1 서류를 제출할 예정이며, 효력 발생은 45일 이내(SEC 전면 검토 시 75일)여야 합니다.

자금 사용처: 운전자본 및 일반 기업 목적. 워런트가 전부 행사될 경우, 이번 거래로 최대 7,080만 주의 신주가 발행되어 기존 주주들의 지분 희석이 발생하지만 단기 유동성은 개선될 것입니다.

Safety Shot, Inc. (NASDAQ:SHOT) a annoncé que le 21 juillet 2025, elle a signé un accord d'achat de titres pour une offre directe enregistrée de 22 993 492 actions ordinaires au prix de 0,461 $ par action, ainsi qu'un placement privé simultané de 45 986 984 bons de souscription non enregistrés d'une durée de cinq ans au prix de 0,125 $ chacun, exerçables au même prix d'exercice de 0,461 $. Ces transactions ont été clôturées le 24 juillet 2025, générant des produits bruts d'environ 16,3 millions de dollars avant frais.

L'agent de placement Dominari Securities LLC recevra une commission en espèces de 8 %, une indemnité de 1 % pour frais et 150 000 $ pour les coûts juridiques et autres dépenses, ainsi que 1 839 479 bons de souscription de cinq ans exerçables à 0,461 $. La société déposera un formulaire S-1 dans les dix jours pour enregistrer la revente des actions issues des bons, avec une entrée en vigueur requise sous 45 jours (75 jours en cas d'examen complet par la SEC).

Utilisation des fonds : fonds de roulement et objectifs généraux de l'entreprise. En supposant l'exercice complet des bons, l'opération pourrait ajouter jusqu'à 70,8 millions de nouvelles actions, diluant significativement les actionnaires actuels tout en améliorant la liquidité à court terme.

Safety Shot, Inc. (NASDAQ:SHOT) gab bekannt, dass am 21. Juli 2025 ein Wertpapierkaufvertrag für ein registriertes Direktangebot von 22.993.492 Stammaktien zu je 0,461 $ sowie eine gleichzeitige private Platzierung von 45.986.984 nicht registrierten fünfjährigen Warrants zu je 0,125 $ mit Ausübungspreis von 0,461 $ unterzeichnet wurde. Die Transaktionen wurden am 24. Juli 2025 abgeschlossen und erzielten Bruttoerlöse von ca. 16,3 Millionen US-Dollar vor Kosten.

Der Platzierungsagent Dominari Securities LLC erhält eine Barausschüttung von 8 %, eine Aufwandspauschale von 1 % sowie 150.000 $ für Rechts- und sonstige Kosten sowie 1.839.479 fünfjährige Warrants mit Ausübungspreis von 0,461 $. Das Unternehmen wird innerhalb von zehn Tagen ein S-1-Formular einreichen, um den Weiterverkauf der Warrants-Aktien zu registrieren, mit Wirksamkeit innerhalb von 45 Tagen (75 Tage bei vollständiger SEC-Prüfung).

Verwendung der Erlöse: Betriebskapital und allgemeine Unternehmenszwecke. Bei vollständiger Ausübung der Warrants könnten bis zu 70,8 Millionen neue Aktien ausgegeben werden, was die bestehenden Aktionäre erheblich verwässert, aber die kurzfristige Liquidität verbessert.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) See Items 5 and 6 of this Schedule 13D. (2) On the basis of (i) 101,628,164 shares of the Issuer's common stock issued and outstanding as of July 15, 2025, reported by the Issuer in its Preliminary Prospectus Supplement, filed with the U.S. Securities and Exchange Commission (the "SEC") on July 15, 2025 (the "Prospectus Supplement"), plus (ii) 987,252 shares of the Issuer's common stock issuable upon the conversion of the Issuer's Series A Perpetual Convertible Preferred Stock beneficially owned by the Reporting Person, plus (iii) 2,035,399 warrants beneficially owned by the Reporting Person, plus (iv) 666,667 options beneficially owned by the Reporting Person, as more fully discussed in Items 5 and 6 of this Schedule 13D.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) See Items 5 and 6 of this Schedule 13D. (2) On the basis of (i) 101,628,164 shares of the Issuer's common stock issued and outstanding as of July 15, 2025, reported by the Issuer in the Prospectus Supplement, plus (ii) 987,252 shares of the Issuer's common stock issuable upon the conversion of the Issuer's Series A Perpetual Convertible Preferred Stock beneficially owned by the Reporting Person, plus (iii) 2,035,399 warrants beneficially owned by the Reporting Person.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) See Items 5 and 6 of this Schedule 13D. (2) On the basis of (i) 101,628,164 shares of the Issuer's common stock issued and outstanding as of July 15, 2025, reported by the Issuer in the Prospectus Supplement, plus (ii) 987,252 shares of the Issuer's common stock issuable upon the conversion of the Issuer's Series A Perpetual Convertible Preferred Stock beneficially owned by the Reporting Person, plus (iii) 2,035,399 warrants beneficially owned by the Reporting Person.


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) See Items 5 and 6 of this Schedule 13D. (2) On the basis of 101,628,164 shares of the Issuer's common stock issued and outstanding as of July 15, 2025, reported by the Issuer in the Prospectus Supplement.


SCHEDULE 13D


Robert S. Ellin
Signature:/s/ Robert S. Ellin
Name/Title:Robert S. Ellin
Date:07/24/2025
Trinad Capital Master Fund, Ltd.
Signature:/s/ Robert S. Ellin
Name/Title:Robert S. Ellin / Managing Member
Date:07/24/2025
Trinad Capital Management, LLC
Signature:/s/ Robert S. Ellin
Name/Title:Robert S. Ellin / Managing Member
Date:07/24/2025
JJAT Corp.
Signature:/s/ Robert S. Ellin
Name/Title:Robert S. Ellin / Principal
Date:07/24/2025

FAQ

How much capital did Safety Shot (SHOT) raise in the July 2025 offering?

The combined registered direct and PIPE offerings generated approximately $16.3 million in gross proceeds.

What are the terms of the new warrants issued by SHOT?

Each warrant is immediately exercisable for one share at $0.461 and carries a five-year term.

How soon will Safety Shot register the resale of warrant shares?

The company must file an S-1 within 10 days of the agreement and have it declared effective within 45 days (75 days if fully reviewed).

What fees will Dominari Securities receive for acting as placement agent?

Dominari earns an 8% cash commission, a 1% expense allowance, $150,000 for legal/out-of-pocket costs, and 1,839,479 warrants exercisable at $0.461.

How will Safety Shot use the proceeds from the offering?

The company intends to use the net proceeds for working capital and general corporate purposes.
Liveone Inc

NASDAQ:LVO

LVO Rankings

LVO Latest News

LVO Latest SEC Filings

LVO Stock Data

83.23M
92.53M
21.62%
27.14%
2.61%
Entertainment
Retail-eating Places
Link
United States
BEVERLY HILLS